Logo.png
Primary Progressive Multiple Sclerosis Clinical Trial Analysis by DelveInsight
February 24, 2021 20:15 ET | DelveInsight Business Research LLP
Los Angeles, USA , Feb. 24, 2021 (GLOBE NEWSWIRE) -- Primary Progressive Multiple Sclerosis Clinical Trial Analysis by DelveInsightThe Primary Progressive Multiple Sclerosis pipeline appears to be...
Logo.png
Recent Analysis on Amyotrophic Lateral Sclerosis Clinical Trials
February 22, 2021 20:30 ET | DelveInsight Business Research LLP
Los Angeles, USA, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Recent Analysis on Amyotrophic Lateral Sclerosis Clinical Trials  DelveInsight reports a complete review on Current and Emerging Therapies in...
Logo.png
Schizophrenia Pipeline: Analysis of 90+ key pipeline therapies, 90+ key pharma competitors, unmet needs, and opportunities
February 16, 2021 20:15 ET | DelveInsight Business Research LLP
Los Angeles, USA, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Schizophrenia Pipeline: Analysis of 90+ key pipeline therapies, 90+ key pharma competitors, unmet needs, and opportunities   Doria and ALKS...
Logo.png
Acute Myeloid Leukemia Pipeline Assessment 2021 report covers Unmet Needs, Key Opportunities, and Major Players
February 15, 2021 20:00 ET | DelveInsight Business Research LLP
Los Angeles, USA, Feb. 15, 2021 (GLOBE NEWSWIRE) -- Acute Myeloid Leukemia Pipeline Assessment 2021 report covers Unmet Needs, Key Opportunities, and Major Players DelveInsight highlights recent...
Logo.png
Global Soft Tissue Sarcoma Pipeline Analysis: A Vast Number of Pipeline Therapies Expected to Get Launched in the Next Decade
February 10, 2021 20:20 ET | DelveInsight Business Research LLP
Los Angeles, USA, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Global Soft Tissue Sarcoma Pipeline Analysis: A Vast Number of Pipeline Therapies Expected to Get Launched in the Next Decade   Analysis of...
Logo.png
Geographic Atrophy Pipeline Report 2021: Therapeutic Evaluation, Drug Profiles, Unmet Needs, Prominent Companies
February 09, 2021 20:30 ET | DelveInsight Business Research LLP
Los Angeles, USA, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Geographic Atrophy Pipeline Report 2021: Therapeutic Evaluation, Drug Profiles, Unmet Needs, Prominent Companies  The growing pipeline of...
Logo.png
Transcatheter Aortic Valve Replacement/Implantation Market Expected To Rise By 2026, Estimates DelveInsight
February 04, 2021 20:20 ET | DelveInsight Business Research LLP
Los Angeles, USA, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Transcatheter Aortic Valve Replacement/Implantation Market Expected To Rise By 2026, Estimates DelveInsight  The rise in the prevalence of...
Logo.png
Novel Therapeutic Approaches for Diffuse Large B-cell Lymphoma
February 03, 2021 20:15 ET | DelveInsight Business Research LLP
Los Angeles, USA , Feb. 03, 2021 (GLOBE NEWSWIRE) -- Novel Therapeutic Approaches for Diffuse Large B-cell Lymphoma The Diffuse Large B-cell Lymphoma treatment spectrum has expanded significantly in...
Logo.png
Artificial Lung Devices Pipeline Looks Promising, a Positive Push to the Market Size Growth in the Future, estimates DelveInsight
February 03, 2021 03:00 ET | DelveInsight Business Research LLP
Los Angeles, USA, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Artificial Lung Devices Pipeline Looks Promising, a Positive Push to the Market Size Growth in the Future, estimates DelveInsight With 20+ key...
Logo.png
Advanced Pancreatic Cancer Pipeline Therapeutics and Analysis, 2021
February 01, 2021 20:00 ET | DelveInsight Business Research LLP
Las Vegas, USA, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Advanced Pancreatic Cancer Pipeline Therapeutics and Analysis, 2021 ERYtech Pharma, GlaxoSmithKline, Galera Therapeutics, Propanc and several...